Condensed Consolidated Statements of Cash Flows (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Cash flows from operating activities:
Net loss	$ (726,306)	$ (781,834)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	1,824	2,336
Stock option compensation expense	14,328	111,437
Share-based compensation - common stock	4,038	7,000
Bad debt expense		5,000
Debt discount amortization	61,364
Noncash finance charges	18,434
Unrealized gain on derivative instruments	(14,232)	(18,167)
Loss on settlement of note and warrant	132,301
Changes in assets and liabilities:
Receivables	57,013	132,747
Prepaid expenses and other current assets	17,072	56,188
Inventory	30,000
Accounts payable, accrued expenses and other liabilities	178,694	(32,745)
Deferred revenue	13,287	(1,600)
Net cash used in operating activities	(212,183)	(519,638)
Cash flows from investing activities:
Purchases of property and equipment	(3,078)
Net cash used in investing activities	(3,078)
Cash flows from financing activities:
Proceeds from note payable	120,000	505,000
Repayment of note and warrant settlement	(118,000)
Proceeds from common stock and warrants	500,000
Net cash provided by financing activities	502,000	505,000
Net increase (decrease) in cash	286,739	(14,638)
Cash at beginning of period	57,009	59,684
Cash at end of period	$ 343,748	$ 74,322